Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
HA Yu, ME Arcila, N Rekhtman, CS Sima… - Clinical cancer …, 2013 - AACR
Purpose: All patients with EGF receptor (EGFR)–mutant lung cancers eventually develop
acquired resistance to EGFR tyrosine kinase inhibitors (TKI). Smaller series have identified …
acquired resistance to EGFR tyrosine kinase inhibitors (TKI). Smaller series have identified …
[HTML][HTML] Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR TKI therapy in 155 patients with EGFR mutant Lung Cancers
AY Helena, ME Arcila, N Rekhtman… - … cancer research: an …, 2013 - ncbi.nlm.nih.gov
Purpose All patients with EGFR mutant lung cancers eventually develop acquired resistance
to EGFR tyrosine kinase inhibitors (TKIs). Smaller series have identified various …
to EGFR tyrosine kinase inhibitors (TKIs). Smaller series have identified various …
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
AY Helena, ME Arcila, N Rekhtman, CS Sima… - Clinical Cancer …, 2013 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: All patients with EGF receptor
(EGFR)–mutant lung cancers eventually develop acquired resistance to EGFR tyrosine …
(EGFR)–mutant lung cancers eventually develop acquired resistance to EGFR tyrosine …
[引用][C] Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
HA YU, ME ARCILA, N REKHTMAN… - Clinical cancer …, 2013 - pascal-francis.inist.fr
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in
155 Patients with EGFR-Mutant Lung Cancers CNRS Inist Pascal-Francis CNRS Pascal …
155 Patients with EGFR-Mutant Lung Cancers CNRS Inist Pascal-Francis CNRS Pascal …
Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.
HA Yu, ME Arcila, N Rekhtman, CS Sima… - … Cancer Research: an …, 2013 - europepmc.org
Purpose All patients with EGF receptor (EGFR)-mutant lung cancers eventually develop
acquired resistance to EGFR tyrosine kinase inhibitors (TKI). Smaller series have identified …
acquired resistance to EGFR tyrosine kinase inhibitors (TKI). Smaller series have identified …
Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers
AY Helena, ME Arcila, N Rekhtman… - … : an official journal …, 2013 - pubmed.ncbi.nlm.nih.gov
Purpose All patients with EGF receptor (EGFR)-mutant lung cancers eventually develop
acquired resistance to EGFR tyrosine kinase inhibitors (TKI). Smaller series have identified …
acquired resistance to EGFR tyrosine kinase inhibitors (TKI). Smaller series have identified …
[PDF][PDF] Analysis of Mechanisms of Acquired Resistance to EGFR TKI therapy in 155 patients with EGFR-mutant Lung Cancers
AY Helena, ME Arcila, N Rekhtman, CS Sima… - academia.edu
EGFR tyrosine kinase inhibitors (TKIs). Smaller series have identified various mechanisms
of resistance, but systematic evaluation of a large number of patients to definitively establish …
of resistance, but systematic evaluation of a large number of patients to definitively establish …
Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.
HA Yu, ME Arcila, N Rekhtman, CS Sima… - … Cancer Research: an …, 2013 - europepmc.org
Purpose All patients with EGF receptor (EGFR)-mutant lung cancers eventually develop
acquired resistance to EGFR tyrosine kinase inhibitors (TKI). Smaller series have identified …
acquired resistance to EGFR tyrosine kinase inhibitors (TKI). Smaller series have identified …